Related Experiment Video

Updated: Jun 19, 2026

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

Growth inhibition of human ovarian cancer cells by blocking STAT3 activation with small interfering RNA

Liying Cai1, Guangmei Zhang, Xiaojing Tong

  • 1Department of Obstetrics and Gynecology, First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin, Heilongjiang 150001, PR China.

European Journal of Obstetrics, Gynecology, and Reproductive Biology
|November 3, 2009
PubMed
Abstract

Insights

Signal transducer and activator of transcription 3 (STAT3) is overactive in ovarian cancer. Inhibiting STAT3 with RNA interference suppressed cancer cell growth and induced apoptosis, indicating STAT3 is a promising therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • Signal transducer and activator of transcription 3 (STAT3) is frequently activated in various cancers, including ovarian cancer.
  • Constitutive STAT3 activation is a hallmark of many malignancies, making it a significant therapeutic target.
  • STAT3 signaling pathways play a crucial role in cancer cell proliferation and survival.

Purpose of the Study:

  • To investigate the therapeutic potential of STAT3 inhibition in ovarian cancer.
  • To evaluate the efficacy of a DNA vector-based STAT3-specific RNA interference approach.
  • To elucidate the molecular mechanisms underlying STAT3 inhibition in ovarian cancer cells.

Main Methods:

  • Utilized a DNA vector-based RNA interference strategy to specifically target and reduce STAT3 expression in human ovarian cancer cells.
  • Assessed the impact of STAT3 knockdown on cellular proliferation and apoptosis in vitro.
  • Analyzed the transcriptional and translational levels of key downstream genes, including cyclin D1, survivin, and VEGF.

Main Results:

  • STAT3 siRNA effectively downregulated the expression of cyclin D1, survivin, and VEGF at both transcriptional and translational levels.
  • Inhibition of STAT3 signaling led to significant suppression of ovarian cancer cell growth in vitro.
  • STAT3 knockdown induced apoptosis in ovarian cancer cells, demonstrating anti-cancer effects.

Conclusions:

  • STAT3 signaling is a critical driver of ovarian cancer progression.
  • Targeting STAT3 with RNA interference represents a promising therapeutic strategy for ovarian cancer.
  • Further research into STAT3-targeted therapies could lead to novel treatment options for ovarian cancer patients.

More Related Videos

Evaluation of Stem Cell Properties in Human Ovarian Carcinoma Cells Using Multi and Single Cell-based Spheres Assays08:39

Evaluation of Stem Cell Properties in Human Ovarian Carcinoma Cells Using Multi and Single Cell-based Spheres Assays

Published on: January 3, 2015

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...